All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
December 2024: Update to nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG)
News
December 2024: Update to nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG)
Management of nausea and vomiting in pregnancy (NVP) and hyperemesis gravidarum (HG)
Updates include:
- Small amendments to self-care measures.
- Cyclizine reclassified as a first line option alongside promethazine.
- Inclusion of doxylamine/pyridoxine as a second line option alongside metoclopramide and prochlorperazine.
- Addition of oral prednisolone as a third line specialist input (amber) option.
- Updated timescales for review.
- Consider combinations of drugs from different classes in women who do not respond to a single anti-emetic.
See here for formulary guidance.
